Potential oral and maxillofacial adverse events associated with glucagon-like peptide-1 receptor agonist administration: a narrative review
{{output}}
Objectives: The aim of this article is to review the general adverse events from the administration of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and emphasize the oral and maxillofacial sequelae. ... ...
